Methotrexate (Zydus Pharmaceuticals (USA) Inc.)
Welcome to the PulseAid listing for the Methotrexate drug offered from Zydus Pharmaceuticals (USA) Inc.. This Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Zydus Pharmaceuticals (USA) Inc. |
NON-PROPRIETARY NAME: | Methotrexate |
SUBSTANCE NAME: | METHOTREXATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-02-09 |
END MARKETING DATE: | 0000-00-00 |
Methotrexate HUMAN PRESCRIPTION DRUG Details:
Item Description | Methotrexate from Zydus Pharmaceuticals (USA) Inc. |
LABELER NAME: | Zydus Pharmaceuticals (USA) Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.5(mg/1) |
START MARKETING DATE: | 2017-02-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68382-775_7e49206c-de28-43ac-8fbf-8bab5b40819c |
PRODUCT NDC: | 68382-775 |
APPLICATION NUMBER: | ANDA207812 |
Other METHOTREXATE Pharmaceutical Manufacturers / Labelers: